Citigroup’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
99,200
-31,488
| -24% | -$641K | ﹤0.01% | 2028 |
|
|
2025
Q1 | $2.37M | Buy |
130,688
+11,329
| +9% | +$206K | ﹤0.01% | 1957 |
|
|
2024
Q4 | $3.02M | Buy |
119,359
+68,629
| +135% | +$1.73M | ﹤0.01% | 1825 |
|
|
2024
Q3 | $1.72M | Buy |
50,730
+25,465
| +101% | +$866K | ﹤0.01% | 2150 |
|
|
2024
Q2 | $935K | Sell |
25,265
-155,715
| -86% | -$5.76M | ﹤0.01% | 2306 |
|
|
2024
Q1 | $7.6M | Buy |
180,980
+118,639
| +190% | +$4.98M | 0.01% | 1035 |
|
|
2023
Q4 | $2.47M | Sell |
62,341
-7,014
| -10% | -$278K | ﹤0.01% | 1496 |
|
|
2023
Q3 | $1.91M | Sell |
69,355
-1,479
| -2% | -$40.7K | ﹤0.01% | 1494 |
|
|
2023
Q2 | $2.4M | Sell |
70,834
-47,071
| -40% | -$1.6M | ﹤0.01% | 1541 |
|
|
2023
Q1 | $4.24M | Buy |
117,905
+54,408
| +86% | +$1.96M | ﹤0.01% | 1181 |
|
|
2022
Q4 | $2.83M | Sell |
63,497
-125,915
| -66% | -$5.61M | ﹤0.01% | 1318 |
|
|
2022
Q3 | $5.32M | Buy |
189,412
+33,735
| +22% | +$948K | ﹤0.01% | 1097 |
|
|
2022
Q2 | $4.2M | Buy |
155,677
+92,158
| +145% | +$2.48M | ﹤0.01% | 1201 |
|
|
2022
Q1 | $2.16M | Sell |
63,519
-55,529
| -47% | -$1.89M | ﹤0.01% | 1725 |
|
|
2021
Q4 | $4.6M | Buy |
119,048
+9,739
| +9% | +$376K | ﹤0.01% | 1341 |
|
|
2021
Q3 | $5.9M | Sell |
109,309
-10,945
| -9% | -$591K | ﹤0.01% | 1206 |
|
|
2021
Q2 | $4.02M | Sell |
120,254
-53,024
| -31% | -$1.77M | ﹤0.01% | 1594 |
|
|
2021
Q1 | $3.57M | Buy |
173,278
+137,687
| +387% | +$2.84M | ﹤0.01% | 1575 |
|
|
2020
Q4 | $624K | Buy |
+35,591
| New | +$624K | ﹤0.01% | 2492 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5100 |
|
|
2019
Q3 | – | Sell |
-200
| Closed | -$1K | – | 5090 |
|
|
2019
Q2 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 5033 |
|
|
2019
Q1 | – | Sell |
-2,082
| Closed | -$6K | – | 5069 |
|
|
2018
Q4 | $6K | Sell |
2,082
-1,351
| -39% | -$3.89K | ﹤0.01% | 4723 |
|
|
2018
Q3 | $23K | Sell |
3,433
-12,638
| -79% | -$84.7K | ﹤0.01% | 4458 |
|
|
2018
Q2 | $121K | Buy |
16,071
+10,845
| +208% | +$81.7K | ﹤0.01% | 3293 |
|
|
2018
Q1 | $183K | Buy |
5,226
+3,266
| +167% | +$114K | ﹤0.01% | 2991 |
|
|
2017
Q4 | $83K | Buy |
1,960
+689
| +54% | +$29.2K | ﹤0.01% | 3533 |
|
|
2017
Q3 | $55K | Buy |
1,271
+70
| +6% | +$3.03K | ﹤0.01% | 3630 |
|
|
2017
Q2 | $44K | Sell |
1,201
-6,593
| -85% | -$242K | ﹤0.01% | 3646 |
|
|
2017
Q1 | $422K | Sell |
7,794
-20,538
| -72% | -$1.11M | ﹤0.01% | 2514 |
|
|
2016
Q4 | $1.5M | Buy |
28,332
+24,260
| +596% | +$1.29M | ﹤0.01% | 2073 |
|
|
2016
Q3 | $246K | Buy |
4,072
+948
| +30% | +$57.3K | ﹤0.01% | 2865 |
|
|
2016
Q2 | $206K | Sell |
3,124
-3,284
| -51% | -$217K | ﹤0.01% | 2841 |
|
|
2016
Q1 | $363K | Buy |
6,408
+4,585
| +252% | +$260K | ﹤0.01% | 2979 |
|
|
2015
Q4 | $428K | Sell |
1,823
-1,476
| -45% | -$347K | ﹤0.01% | 2469 |
|
|
2015
Q3 | $522K | Buy |
3,299
+1,840
| +126% | +$291K | ﹤0.01% | 2173 |
|
|
2015
Q2 | $552K | Sell |
1,459
-394
| -21% | -$149K | ﹤0.01% | 2079 |
|
|
2015
Q1 | $775K | Sell |
1,853
-856
| -32% | -$358K | ﹤0.01% | 1944 |
|
|
2014
Q4 | $741K | Buy |
2,709
+2,119
| +359% | +$580K | ﹤0.01% | 2067 |
|
|
2014
Q3 | $114K | Sell |
590
-78
| -12% | -$15.1K | ﹤0.01% | 3047 |
|
|
2014
Q2 | $163K | Sell |
668
-2,480
| -79% | -$605K | ﹤0.01% | 2738 |
|
|
2014
Q1 | $834K | Sell |
3,148
-1,780
| -36% | -$472K | ﹤0.01% | 1704 |
|
|
2013
Q4 | $1.79M | Buy |
4,928
+2,572
| +109% | +$934K | ﹤0.01% | 1439 |
|
|
2013
Q3 | $1.25M | Buy |
2,356
+2,163
| +1,121% | +$1.15M | ﹤0.01% | 1429 |
|
|
2013
Q2 | $46K | Buy |
+193
| New | +$46K | ﹤0.01% | 3809 |
|